Injection site irritation occurs infrequently with proper technique
Cagrilintide is engineered to extend that biology into a once-weekly molecule with amylin and calcitonin receptor activity
If standard doses are not tolerated, clinically appropriate alternatives might include slower titration (still within SmPC guidelines), switching to a different GLP-1 receptor agonist, considering other medication classes, enhancing diet/lifestyle support, or specialist review
That regulatory status is important for patients to understand, but it should be separated from the biological research
This is a general pattern, not a rule
A compromised gut barrier, often associated with leaky gut syndrome, allows harmful substances to pass into the bloodstream, exacerbating inflammation